Champions Oncology share price logo

Champions Oncology

NASDAQ: CSBR

$4.90

-0.02

(-0.41%)

Live

as on

Champions Oncology Stock Performance

as on August 28, 2026 at 2:35 am IST

  • Day's Low

    Day's High

    $4.87
    $4.93
    downward going graph

    0.61%

    Downside

    0.61%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.83
    $8.74
    downward going graph

    1.43%

    Downside

    78.37%

    Upside

    downward going graph

Champions Oncology share price movements today

Previous Close
$4.92
Open
$4.89
Volume
41.3K
Market Cap
$69.1M
Day's Low - High
$4.87 - $4.93
52 Week Low - High
$4.83 - $8.74

Champions Oncology Historical Returns

1 Month Return
-17.82 %
3 Month Return
-15.16 %
1 Year Return
-24.55 %
3 Year Return
-24.55 %
5 Year Return
-50.05 %

Champions Oncology Stock Fundamentals & Key Indicators

Check Champions Oncology market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$69.1M

EPS (TTM)

0.12

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.61%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

348.0K

Revenue (TTM)

59.4M

Profit Margin

-1.98%

Return On Equity TTM

-29.97%

Champions Oncology vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Champions Oncology with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$69.1M-50.05%NA-1.98%NA
BUY$45.3B641.42%NA0.00%NA
BUY$138.8B176.54%31.9535.00%NA
BUY$55.4B-58.45%NA-141.43%NA
BUY$85.3B25.67%20.6227.87%44.39%

Stock Returns calculator for Champions Oncology Stock including INR - Dollar returns

The Champions Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Champions Oncology investment value today

Current value as on today

₹80,907

Returns

-₹19,093

(-19.09%)

Returns from Champions Oncology Stock

-₹25,758 (-25.76%)

Dollar Impact

₹6,664 (+6.66%)

Analyst Recommendation on Champions Oncology Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Champions Oncology. Average target price of $12

Champions Oncology Share Price Target

Get share price movements and forecasts by analysts on Champions Oncology.

What analysts predicted

59.17%UPSIDE

Target Price

$12

Current Price

$4.9

Analyzed by

6 Analysts

Target

$12.00

Champions Oncology target price $12, a slight upside of 59.17% compared to current price of $4.9. According to 6 analysts rating.

Indian Investors' Interest in Champions Oncology Stock

Search interest for Champions Oncology Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:13% versus previous 30 day period

Champions Oncology Quarterly Profit & Loss

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Total Revenue
12
14
14
13
17
12
13
15
16
13
Gross Profit
4
6
6
6
10
5
6
7
7
7
Operating Income
-2
0
1
0
4
-1
0
0
0
0
EBITDA
-2
0
1
1
4
-1
0
0
0
0
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
0
1
0
4
-1
0
0
0
0
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-2
0
1
0
4
-1
0
0
0
0
Net Profit Margin
-21.05%
-0.78%
9.34%
5.40%
26.38%
-14.85%
-3.33%
1.99%
-1.68%
-5.27%

Champions Oncology Annual Profit & Loss

All numbers in Millions USD

Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Apr 2026
Total Revenue
15
20
27
32
41
49
53
50
56
59
Gross Profit
5
9
12
15
19
25
24
20
28
28
Operating Income
-6
-1
0
-1
0
0
-4
-6
4
-1
EBITDA
-6
0
0
0
1
2
-3
-5
6
0
Interest Expense
-
-
0
0
0
0
-
0
0
-
Depreciation
0
0
0
0
1
1
2
1
1
1
Income Before Tax
-6
-1
0
-1
0
0
-5
-7
4
0
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-6
-1
0
-2
0
0
-5
-7
4
-1
Net Profit Margin
-44.67%
-7.29%
0.47%
-6.52%
0.88%
1.12%
-9.90%
-14.51%
8.26%
-1.98%

Champions Oncology Quarterly Cash Flow

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Net Income
0
1
0
4
-1
0
0
0
0
Operating Cash Flow
-1
0
0
0
6
0
-1
-1
-1
Investing Cash Flow
0
-
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
-
0
0
0
0
0
Change in Cash
-1
0
0
0
6
0
-1
-1
-2

Champions Oncology Annual Cash Flow

All numbers in Millions USD

Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Apr 2026
Net Income
-1
0
-1
0
0
-5
-7
4
-1
Operating Cash Flow
-1
1
2
-1
6
3
-6
7
-4
Investing Cash Flow
-1
0
-2
-3
-2
-2
0
0
0
Financing Cash Flow
0
1
4
1
0
0
0
0
0
Change in Cash
-2
2
5
-3
4
1
-7
7
-4

Mutual Funds that own Champions Oncology Stock

Check out the Mutual Funds with significant holdings in Champions Oncology.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.108838%
292993
Fidelity Concord Street Trust
0.457672%
63587
LoCorr Investment Trust
0.340546%
47314
SCHWAB CAPITAL TRUST
0.049332%
6854
VANGUARD INSTITUTIONAL INDEX FUNDS
0.046978%
6527

Global Institutional Holdings in Champions Oncology

Funds
Holdings
Vanguard
2.11%
iShares
0.21%

Insights on Champions Oncology

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 496.3% return, outperforming this stock by 521.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 33.7% return, outperforming this stock by 59.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 16.55M → 13.83M (in $), with an average decrease of 16.4% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, CSBR stock has moved down by -18.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 299.0K → -729.0K (in $), with an average decrease of 177.3% per quarter

About Champions Oncology

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
OrganisationChampions Oncology
HeadquartersOne University Plaza, Hackensack, NJ, United States, 07601
IndustryBiotechnology
CEOMr. Robert Brainin
E-voting on sharesClick here to vote

Key Management of Champions Oncology

Name

Title

Mr. David Barry Miller M.B.A.

Chief Financial Officer

Dr. Maria Mancini Ph.D.

Chief Operating Officer

Dr. Marianna Zipeto Ph.D.

Executive Vice President of Growth, Strategy & Enablement

Dr. Ronnie Morris M.D.

Executive Chair

Mr. Robert Brainin

CEO & Director

FAQs

What is Champions Oncology share price today?

Champions Oncology share price today is $4.90 as on . Champions Oncology share today touched a day high of $4.93 and a low of $4.87.

What is the 52 week high and 52 week low for Champions Oncology share?

Champions Oncology share touched a 52 week high of $8.74 on and a 52 week low of $4.83 on . Champions Oncology stock price today i.e. is trending at $4.90,which is 43.94% down from its 52 week high and 1.45% up from its 52 week low.

What is Champions Oncology's market capitalisation today?

Champions Oncology market capitalisation is $0.00T as on .

How to invest in Champions Oncology Stock (CSBR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Champions Oncology on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Champions Oncology Shares that will get you 0.3061 shares as per Champions Oncology share price of $4.90 per share as on August 27, 2026 at 9:05 pm IST.

What is the minimum amount required to buy Champions Oncology Stock (CSBR) from India?

Indian investors can start investing in Champions Oncology (CSBR) shares with as little as ₹95.53 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.30 in Champions Oncology stock (as per the Rupee-Dollar exchange rate as on ). Based on Champions Oncology share’s latest price of $4.90 as on August 27, 2026 at 9:05 pm IST, you will get 2.0408 shares of Champions Oncology. Learn more about fractional shares .

What are the returns that Champions Oncology has given to Indian investors in the last 5 years?

Champions Oncology stock has given -50.05% share price returns and 30.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?